Inotuzumab ozogamicin versus FLAG-Ida in the treatment of...

  • Main
  • 2019 / 10
  • Inotuzumab ozogamicin versus FLAG-Ida in the treatment of...

Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia – real-world resource use data

Lecat, Catherine S. Y., Besley, Caroline, Hough, Rachael E., Khwaja, Asim, Furness, Caroline, Marks, David I., Fielding, Adele K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2019.1672057
Date:
October, 2019
File:
PDF, 716 KB
2019
Conversion to is in progress
Conversion to is failed